awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q26773309-E0E3D4E4-21D6-4298-A4C4-203827CE3290
Q26773309-E0E3D4E4-21D6-4298-A4C4-203827CE3290
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26773309-E0E3D4E4-21D6-4298-A4C4-203827CE3290
Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy
P2860
Q26773309-E0E3D4E4-21D6-4298-A4C4-203827CE3290
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26773309-E0E3D4E4-21D6-4298-A4C4-203827CE3290
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
44bd93bf9a8c9d4062c1e458fe42c7e5b729555b
P2860
Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor.